
Gary W. Counts
Examiner (ID: 5481, Phone: (571)272-0817 , Office: P/1678 )
| Most Active Art Unit | 1678 |
| Art Unit(s) | 1641, 1678, 1677 |
| Total Applications | 1282 |
| Issued Applications | 604 |
| Pending Applications | 186 |
| Abandoned Applications | 499 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17721643
[patent_doc_number] => 20220214365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => Methods of Detecting Anti-folic acid Antibodies and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/699706
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699706
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/699706 | Methods of detecting anti-folic acid antibodies and uses thereof | Mar 20, 2022 | Issued |
Array
(
[id] => 19061224
[patent_doc_number] => 11940450
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Biomarker panel for non-invasive diagnosis of congenital renal dysfunction
[patent_app_type] => utility
[patent_app_number] => 17/695381
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 7
[patent_no_of_words] => 8368
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695381
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/695381 | Biomarker panel for non-invasive diagnosis of congenital renal dysfunction | Mar 14, 2022 | Issued |
Array
(
[id] => 17706009
[patent_doc_number] => 20220206015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => MARKER FOR STATIN TREATMENT STRATIFICATION IN HEART FAILURE
[patent_app_type] => utility
[patent_app_number] => 17/693789
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17693789
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/693789 | MARKER FOR STATIN TREATMENT STRATIFICATION IN HEART FAILURE | Mar 13, 2022 | Abandoned |
Array
(
[id] => 17674157
[patent_doc_number] => 20220187324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => MULTIPLEXED DIAGNOSTIC TO RECOGNIZE CONCENTRATIONS OF RELATED PROTEINS AND PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/684296
[patent_app_country] => US
[patent_app_date] => 2022-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12072
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17684296
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/684296 | MULTIPLEXED DIAGNOSTIC TO RECOGNIZE CONCENTRATIONS OF RELATED PROTEINS AND PEPTIDES | Feb 28, 2022 | Abandoned |
Array
(
[id] => 19275493
[patent_doc_number] => 12025616
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Method and composition for detection of proteolytic products and diagnosis of malignant neoplastic disease
[patent_app_type] => utility
[patent_app_number] => 17/679493
[patent_app_country] => US
[patent_app_date] => 2022-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6854
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17679493
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/679493 | Method and composition for detection of proteolytic products and diagnosis of malignant neoplastic disease | Feb 23, 2022 | Issued |
Array
(
[id] => 19608891
[patent_doc_number] => 12157757
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Cation exchange chromatography methods
[patent_app_type] => utility
[patent_app_number] => 17/679640
[patent_app_country] => US
[patent_app_date] => 2022-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5399
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17679640
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/679640 | Cation exchange chromatography methods | Feb 23, 2022 | Issued |
Array
(
[id] => 18583249
[patent_doc_number] => 20230265509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => NOVEL TARGETS FOR THE TREATMENT AND DIAGNOSIS OF PATIENTS WITH ATHEROSCLEROSIS AND ENHANCED RISK OF END ORGAN DAMAGE
[patent_app_type] => utility
[patent_app_number] => 17/676072
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17676072
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/676072 | NOVEL TARGETS FOR THE TREATMENT AND DIAGNOSIS OF PATIENTS WITH ATHEROSCLEROSIS AND ENHANCED RISK OF END ORGAN DAMAGE | Feb 17, 2022 | Abandoned |
Array
(
[id] => 17628525
[patent_doc_number] => 20220163540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => DETECTION OF GLUCURONIDATED AND 3-BROMOTYROSINE
[patent_app_type] => utility
[patent_app_number] => 17/668261
[patent_app_country] => US
[patent_app_date] => 2022-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17668261
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/668261 | Detection of glucuronidated and 3-bromotyrosine | Feb 8, 2022 | Issued |
Array
(
[id] => 19014184
[patent_doc_number] => 11921108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Methods for determining amount of functional albumin
[patent_app_type] => utility
[patent_app_number] => 17/667376
[patent_app_country] => US
[patent_app_date] => 2022-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 10218
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17667376
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/667376 | Methods for determining amount of functional albumin | Feb 7, 2022 | Issued |
Array
(
[id] => 20273050
[patent_doc_number] => 12442826
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Lateral flow test strip readers, cartridges and related methods
[patent_app_type] => utility
[patent_app_number] => 17/590325
[patent_app_country] => US
[patent_app_date] => 2022-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 22
[patent_no_of_words] => 11109
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17590325
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/590325 | Lateral flow test strip readers, cartridges and related methods | Jan 31, 2022 | Issued |
Array
(
[id] => 19021316
[patent_doc_number] => 20240077487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => METHOD FOR THE DETECTION OF LUNG CANCER
[patent_app_type] => utility
[patent_app_number] => 18/261392
[patent_app_country] => US
[patent_app_date] => 2022-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10245
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261392
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/261392 | METHOD FOR THE DETECTION OF LUNG CANCER | Jan 12, 2022 | Abandoned |
Array
(
[id] => 18903946
[patent_doc_number] => 20240019431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => AUTOANTIBODIES AS BIOMARKERS FOR LIPODYSTROPHY
[patent_app_type] => utility
[patent_app_number] => 18/251926
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15170
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251926
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/251926 | AUTOANTIBODIES AS BIOMARKERS FOR LIPODYSTROPHY | Dec 21, 2021 | Pending |
Array
(
[id] => 18686336
[patent_doc_number] => 11782065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-10
[patent_title] => Kits and methods for prediction and treatment of preeclampsia
[patent_app_type] => utility
[patent_app_number] => 17/558248
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 19
[patent_no_of_words] => 8852
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17558248
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/558248 | Kits and methods for prediction and treatment of preeclampsia | Dec 20, 2021 | Issued |
Array
(
[id] => 18973269
[patent_doc_number] => 20240053361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => USE OF ALARMINS AS BIOMARKERS FOR ASSESSING ISCHEMIA-REPERFUSION INJURY SEVERITY AFTER SOLID ORGAN TRANSPLANTATION
[patent_app_type] => utility
[patent_app_number] => 18/257697
[patent_app_country] => US
[patent_app_date] => 2021-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5335
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18257697
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/257697 | USE OF ALARMINS AS BIOMARKERS FOR ASSESSING ISCHEMIA-REPERFUSION INJURY SEVERITY AFTER SOLID ORGAN TRANSPLANTATION | Dec 13, 2021 | Abandoned |
Array
(
[id] => 20757670
[patent_doc_number] => 12650434
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-09
[patent_title] => Methods of monitoring inflammatory bowel diseases
[patent_app_type] => utility
[patent_app_number] => 18/266497
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9293
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266497
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/266497 | Methods of monitoring inflammatory bowel diseases | Dec 9, 2021 | Issued |
Array
(
[id] => 19068593
[patent_doc_number] => 20240103019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => USE OF THE EMM ANTIGEN AS A BIOMARKER OF INHERITED GPI DEFICIENCIES
[patent_app_type] => utility
[patent_app_number] => 18/256453
[patent_app_country] => US
[patent_app_date] => 2021-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18256453
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/256453 | USE OF THE EMM ANTIGEN AS A BIOMARKER OF INHERITED GPI DEFICIENCIES | Dec 7, 2021 | Pending |
Array
(
[id] => 18956586
[patent_doc_number] => 20240044913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => METHOD FOR MEASUREMENT OF CELL FREE NUCLEOPROTEIN CHROMATIN FRAGMENTS
[patent_app_type] => utility
[patent_app_number] => 18/253768
[patent_app_country] => US
[patent_app_date] => 2021-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9269
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18253768
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/253768 | METHOD FOR MEASUREMENT OF CELL FREE NUCLEOPROTEIN CHROMATIN FRAGMENTS | Nov 24, 2021 | Pending |
Array
(
[id] => 17674160
[patent_doc_number] => 20220187327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => ASSAYS FOR DETECTING THE PRESENCE OR AMOUNT OF AN ANTI-DRUG ANTIBODY
[patent_app_type] => utility
[patent_app_number] => 17/534012
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12785
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17534012
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/534012 | Assays for detecting the presence or amount of an anti-drug antibody | Nov 22, 2021 | Issued |
Array
(
[id] => 18981364
[patent_doc_number] => 11906528
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => Kits and methods to distinguish false labor and true labor
[patent_app_type] => utility
[patent_app_number] => 17/525717
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 18
[patent_no_of_words] => 11226
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17525717
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/525717 | Kits and methods to distinguish false labor and true labor | Nov 11, 2021 | Issued |
Array
(
[id] => 19433867
[patent_doc_number] => 20240302365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => METHOD FOR DIAGNOSING CHRONIC URTICARIA
[patent_app_type] => utility
[patent_app_number] => 18/255680
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18255680
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/255680 | METHOD FOR DIAGNOSING CHRONIC URTICARIA | Nov 11, 2021 | Abandoned |